The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Transient Ischemic Attack (TIA)

Brief Episode of Neurological Dysfunction with High Risk of Subsequent Stroke

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Nöroloji department. Book Appointment →

What is Transient Ischemic Attack (TIA)?

Transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused by focal brain, spinal cord or retinal ischemia, without permanent infarction (tissue-based definition); typical duration <1 hour, usually <10 minutes.

Epidemiology: 200,000–500,000 TIA events annually in the United States; up to 30% of strokes are preceded by TIA; warning sign of impending stroke.

Pathophysiology: temporary occlusion of cerebral artery by thromboembolism (cardioembolic 30%, large-artery atherosclerosis 25%, small-vessel disease 20%, other rare causes); spontaneous recanalization before infarction.

Stroke risk after TIA: 5% at 48 hours, 10% at 90 days; aggressive antithrombotic therapy and risk factor management within 24 hours reduces risk by 80%.

Symptoms

Sudden onset focal neurological deficit lasting minutes to <24 hours, typically <10 minutes
Hemiparesis or hemiplegia (unilateral arm or leg weakness)
Hemisensory loss (numbness, tingling on one side)
Aphasia (expressive or receptive language difficulties)
Dysarthria (slurred speech)
Visual disturbances: amaurosis fugax (transient monocular blindness), hemianopia, double vision
Vertigo, ataxia, gait imbalance (posterior circulation TIA)
Crossed signs (cranial nerve dysfunction with contralateral hemiparesis suggesting brainstem)
Confusion, decreased level of consciousness (less common, severe cases)
Complete resolution within 24 hours by definition (most resolve within 1 hour)
Headache (may accompany TIA but more common in stroke and migraine aura)

Risk Factors

Hypertension (most important modifiable risk factor)
Diabetes mellitus (2× increased risk)
Smoking (2–4× increased risk)
Atrial fibrillation (5× increased risk for cardioembolic stroke)
Hyperlipidemia (LDL >130 mg/dL)
Carotid artery stenosis (especially symptomatic >70%)
Coronary artery disease, peripheral artery disease
Family history of stroke
Age >55 years (risk doubles every decade)
Male sex (slight predominance)
African American ethnicity (higher risk and severity)
Sickle cell disease
Migraine with aura (especially in young women)
Hypercoagulable states: antiphospholipid syndrome, factor V Leiden, protein C/S deficiency
Patent foramen ovale (paradoxical embolism in young patients)
Atherosclerosis

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Sudden onset weakness, numbness or facial droop (CALL EMERGENCY — same as stroke)
  • Sudden speech difficulty, confusion or visual loss
  • Sudden severe dizziness, balance loss or coordination problem
  • Recent symptoms now resolved (still requires urgent evaluation within 24 hours)
  • Previous TIA or stroke with new symptoms
  • Symptoms suggesting carotid disease or cardioembolism
  • Recurrent transient neurological events

Treatment Methods

01
Urgent evaluation: same emergency department workup as stroke; ABCD2 score for risk stratification (Age ≥60, Blood pressure ≥140/90, Clinical features, Duration, Diabetes), high risk score 4–7 needs urgent admission
02
Imaging: brain MRI with diffusion-weighted imaging within 24 hours (gold standard, identifies infarction in 30–50% of clinical TIA cases); CT brain to rule out hemorrhage
03
Vascular imaging: carotid duplex ultrasound, CT or MR angiography of carotid and intracranial arteries; identifies symptomatic carotid stenosis (>70% requires intervention)
04
Cardiac evaluation: 12-lead ECG, echocardiography (consider transesophageal for cardioembolic source), 24–48 hour Holter monitoring or extended cardiac monitoring for AF detection
05
Laboratory tests: lipid profile, fasting glucose, HbA1c, comprehensive metabolic panel, coagulation profile, ESR/CRP, in selected cases hypercoagulable workup
06
Antiplatelet therapy: aspirin 81–325 mg/day initiated immediately for non-cardioembolic TIA; clopidogrel 75 mg/day alternative or in aspirin allergy
07
Dual antiplatelet therapy (DAPT): aspirin plus clopidogrel for 21 days post-event in high-risk minor stroke or TIA (CHANCE/POINT trials); reduces 90-day stroke risk by 30–40%
08
Anticoagulation for cardioembolic TIA: direct oral anticoagulants (DOACs: dabigatran, rivaroxaban, apixaban, edoxaban) preferred over warfarin for atrial fibrillation
09
Hypertension management: aggressive blood pressure control (target <130/80 mmHg), ACE inhibitor/ARB plus thiazide or calcium channel blocker; not too rapidly in acute phase
10
Statin therapy: high-intensity statin (atorvastatin 80 mg or rosuvastatin 20–40 mg) for LDL <70 mg/dL goal; SPARCL trial demonstrated 16% relative risk reduction
11
Diabetes management: HbA1c <7% goal, lifestyle modification, metformin or other agents; SGLT-2 inhibitors and GLP-1 agonists with cardiovascular benefit
12
Smoking cessation: behavioral counseling, nicotine replacement, varenicline, bupropion; 50% risk reduction within 5 years of cessation
13
Carotid intervention: carotid endarterectomy (CEA) or stenting for symptomatic stenosis >70% within 2 weeks of TIA; CEA preferred for >70% stenosis in low surgical risk patients
14
Atrial fibrillation management: anticoagulation per CHA₂DS₂-VASc score, rate or rhythm control; left atrial appendage occlusion in patients unable to tolerate anticoagulation
15
Lifestyle modifications: Mediterranean diet, regular exercise (150 min/week moderate intensity), weight management (BMI 18.5–24.9), alcohol moderation
16
Patent foramen ovale closure: in selected young patients (<60) with cryptogenic stroke and high-risk PFO; RESPECT, CLOSE, REDUCE trials supportive
17
Patient education: stroke recognition (FAST: Face drooping, Arm weakness, Speech difficulty, Time to call), medication compliance, lifestyle changes, follow-up importance
18
Long-term outcomes: aggressive management reduces 5-year stroke risk from 25–30% to 7–10%; quality of life largely preserved with appropriate prevention
19
Multidisciplinary follow-up: neurology, cardiology, vascular surgery (for carotid intervention), endocrinology (for diabetes), primary care; outpatient follow-up within 1 week, 1 month, 6 months

Which Department to Visit?

You can visit our Nöroloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Nöroloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Transient Ischemic Attack (TIA)

Nöroloji

Transient ischemic attack is a warning sign caused by a temporary interruption of blood flow to the brain, presenting with short-lived neurological symptoms.

Headache and Migraine

Nöroloji

What you need to know about headache types, migraine attacks, and triggering factors.

Low Back Pain

Nöroloji

Learn about the most common causes of low back pain, risk factors, and appropriate treatment approaches.

Neck Pain and Cervical Disc Herniation

Nöroloji

Learn about the symptoms and treatment options for cervical disc herniation and problems in the neck region.

Epilepsy

Nöroloji

Accurate information about epilepsy, types of seizures, and recommendations for patients and families.

Parkinson Disease

Nöroloji

Parkinson disease is caused by progressive degeneration of dopaminergic neurons and alpha-synuclein accumulation; well-timed therapy substantially improves function and quality of life.

Alzheimer's Disease and Dementia

Nöroloji

Information about early signs, diagnosis, and the care process for Alzheimer's and other types of dementia.

Multiple Sclerosis (MS)

Nöroloji

What is multiple sclerosis, who is at risk, and which treatments are applied?

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.